INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease.
Media coverage provided for informational purposes only and third party links provided as a resource. INmune Bio does not control the content of third parties. XPro1595, Quellor, LIVNate, INB03, INKmune and other drug candidates, have not yet been shown to be safe or effective, and has not been approved by any regulatory body.
Media coverage provided for informational purposes only and third party links provided as a resource. INmune Bio does not control the content of third parties. XPro1595, Quellor, LIVNate, INB03, INKmune and other drug candidates, have not yet been shown to be safe or effective, and has not been approved by any regulatory body.
Location: United States, Florida, Boca Raton
Employees: 11-50
Founded date: 2015
Mentions in press and media 27
| Date | Title | Description |
| 26.01.2025 | Be Bio: Clinical Stage Company Closes $92 Million (Series C) | Be Biopharma, Inc. (Be Bio), a leader in B Cell Medicines (BCMs), announced the closing of its $92 million Series C financing. The funding round includes participation from new investor Nextech with existing investors, including ARCH Ventur... |
| 18.12.2024 | Houston's Innovation Surge: A Year of Transformative Growth | Houston is buzzing. The city, often known for its oil and gas roots, is now a fertile ground for innovation. Startups are sprouting like wildflowers, each one bringing fresh ideas and solutions to the table. In 2024, several key players eme... |
| 18.12.2024 | Houston's Entrepreneurial Surge: Lessons from a Decade of Grit and Growth | Houston is buzzing. The job market is thriving, and entrepreneurship is on fire. This city is not just a dot on the map; it’s a startup ecosystem ranked among the top 50 globally. Climate tech is leading the charge, with the market projecte... |
| 17.12.2024 | Houston med school lands $3.5M grant to rollout genetic telehealth platform for underserved newborns | Baylor College of Medicine received $3.5 million to help hospitals in Texas better care for and diagnose some of the state's most vulnerable patients. The funds come from the National Human Genome Research Institute for the Making Genomics ... |
| 17.12.2024 | 10 years in: Houston entrepreneur reflects on lessons learned | Just as the job market is soaring, so is the state of entrepreneurship in America. And increasingly, people are launching their businesses in Houston. As InnovationMap reported, our city is a top startup ecosystem, now ranked among the top ... |
| 17.12.2024 | Houston e-commerce platform expands logistics network with acquisition of fulfillment operations arm | A Houston e-commerce unicorn has made its latest strategic acquisition. Cart.com, which operates a multichannel commerce platform, announced that it has acquired Guthy-Renker's wholly-owned fulfillment operations arm OceanX. The terms of th... |
| 12.12.2024 | Houston expert: How leaders can manage divisive topics in the workplace to maintain a unified culture | Social issues to economic pressures and personal challenges are all stressors businesses must face and navigate. When employees face these obstacles, they can impact their performance. Amid it all, business leaders must adopt proactive stra... |
| 12.12.2024 | 3 clean energy innovators make Forbes list of top young energy professionals | A handful of Houstonians have been named to the Forbes 30 Under 30 Energy and Green Tech list for 2025. Kip Daujotas is an investment associate at Aramco Ventures, a $7.5 billion venture capital arm of the world's largest energy company. Ho... |
| 11.12.2024 | Houston's Innovation Landscape: A Tapestry of Diversity and Progress | Houston is a city of contrasts. It’s a melting pot of cultures, a hub of innovation, and a battleground for health challenges. The recent partnership between OmniScience and INmune Bio shines a spotlight on the city’s commitment to tackling... |
| 11.12.2024 | Houston's Construction Boom: A New Era of Innovation and Opportunity | Houston is a city that thrives on growth. It’s a sprawling metropolis, constantly evolving, where the skyline tells a story of ambition and resilience. Recently, the construction industry here has caught the eye of innovators. Enter Mercato... |
Show more